Chemoinformaics analysis of 2,4,6-Trimethoxyphenol
| Molecular Weight | 184.191 | nRot | 3 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 6 |
| Exact Molecular Weight | 184.074 | nRing | 1 |
| Solubility: LogS | -1.799 | nHRing | 0 |
| Solubility: LogP | 1.202 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 26.2395 |
| nHD | 1 | BPOL | 17.2465 |
| QED | 0.771 |
| Synth | 1.656 |
| Natural Product Likeliness | 0.486 |
| NR-PPAR-gamma | 0.191 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.01 |
| HIA | 0.006 |
| CACO-2 | -4.613 |
| MDCK | 0.0000222 |
| BBB | 0.488 |
| PPB | 0.808524 |
| VDSS | 0.805 |
| FU | 0.15549 |
| CYP1A2-inh | 0.817 |
| CYP1A2-sub | 0.948 |
| CYP2c19-inh | 0.197 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.05 |
| CYP2c9-sub | 0.851 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.921 |
| CYP3a4-inh | 0.038 |
| CYP3a4-sub | 0.331 |
| CL | 11.852 |
| T12 | 0.879 |
| hERG | 0.042 |
| Ames | 0.037 |
| ROA | 0.089 |
| SkinSen | 0.904 |
| Carcinogencity | 0.063 |
| EI | 0.979 |
| Respiratory | 0.381 |
| NR-Aromatase | 0.457 |
| Antiviral | No |
| Prediction | 0.869314 |